反応式
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[C:15](=[O:16])[N:11]3[CH2:12][CH2:13][CH2:14][N:10]3[C:9]=2[C:17]2[CH:22]=[CH:21][N:20]=[C:19](SC)[N:18]=2)=[CH:4][CH:3]=1.[CH3:25]O.O[O:28][S:29]([O-:31])=O.[K+].S([O-])(O[O-])(=O)=O.[K+].[K+]>C1COCC1.O.C([O-])(O)=O.[Na+]>[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[C:15](=[O:16])[N:11]3[CH2:12][CH2:13][CH2:14][N:10]3[C:9]=2[C:17]2[CH:22]=[CH:21][N:20]=[C:19]([S:29]([CH3:25])(=[O:31])=[O:28])[N:18]=2)=[CH:4][CH:3]=1参加物
8
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
To a solution of 2-(4-fluorophenyl)-3-(2-methylsulfanyl-pyrimidin-4-yl)-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-one, 4, (1.3 g, 3.8 mmol) in THF:methanol (56 mL of a 1:1 mixture) is added dropwise a solution of Oxone® (potassium peroxymonosulfate) (9.34 g, 15.2 mmol) in water (42 mL). The reaction is stirred 1 hour at room temperature, diluted with aqueous NaHCO3 and extract three times with ethyl acetate. The organic layers are combined, dried, and concentrated in vacuo too afford the crude desired product which is used without further purification.
後処理
- extractionextract three times with ethyl acetate
- customdried
- concentrationconcentrated in vacuo
出典と根拠
- ORDレコード
- ord-245f887f4b944d7aa69c92de847409da
- 出典データセット
- uspto-grants-2006_08
- 特許番号
- US07087615B2
関連ノート
読み込み中…